3Jorgersen KA, Stofferson E. On the inhibitory effects of albumin on platelet aggregation.Thrombos Res,1980,17:13- 18.
4Tobias MD,Wambold D,Pilla MA,et al. Differential effects of serial hemodilution with hydroxyethyl starch, albumin and 0.9% saline on whole blood coagulation. J Clin Anesth, 1998, 8:366-371.
5Dietrich G, Orth D, Itaupt W, et al. Primary hemostasis in hemodilution- infusion solutions. Infusionstherapie, 1990,17:214-216.
6Wagner BK, Amelio LF. Pharmacologic and clinical considerations in selecting crystalloid, colloidal and oxygen - carrying resuscitation fluids. Part 1. CAin Pharmacol, 1993, 12:335-346.
7Evans PA, Glenn JR, Iteptinstall S, et al. Effects of gelatinbased resuscitation fluids on platelet aggregation. Br J Anesth,1998, 81:198- 292.
8Mardd SN, Saunders FM, Allen H, et al. Reduced quality of dot formation with gelatin - based plasma substitutes. Br J Anaesth, 1998, 80:204 -207.
9Jonge E, Levi M, Berends F, et al. Impaired haemostasis by intravenous administration of a gelatinbased plasma expander in human subjects. Thromb Haemost, 1998,79: 286-290.
10Treib J, Tlaass A, Pindur G, et al. Coagulation disorders caused by hydorxyethyl starch. Thromb Haemost, 1997, 78:974 - 983.
二级参考文献13
1Hebert PC, Wells G, Blajchman MA, et al. Amulticenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med, 1999,340:409-417.
2Hebert PC,Yetisir E,Martin C,et al. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med, 2001,29: 227-234.
3Vincent JL, Baron JF, Reinhart K, et al. Anemia and blood transfusion in critically ill patients. JAMA, 2002,288:1499-1507.
4Isbister JP. Is the clinical significance of blood storage lesions underestimated? TATM, 2003,5: 356-362.
5Gan TJ. Intraoperative fluid management and choice of fluid. ASA 54th Ann Refresher Course Lectures, San Francisco, 2003. 236.
6McIlroy DR,Kharasch ED. Acute intravascular volume expansion with rapidly administered crystalloid or colloid in the setting of moderate hypovolemia. Anesth Analg,2003,96:1572-1577.
7Friedman Z,Berkenstadt H,Preisman S,et al. A Comparison of lactated Ringer' s solution to hydroxyethy starch 6 % in a model of severe hemorrhagic shock and continuous bleeding in dogs. Anesth Analg, 2003,96:39-45.
8Lang K,Boldt J,Suttner S,et al. Colloids versus crystalloids and tissue oxygen tension in patients undergoing major abdominal surgery. Anesth Analg, 2001,93: 405-409.
9Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients:Systematic review of randomized controlled trials. BMJ, 1998,317:235-240.
10Jungheinrich C, Scharpf R, Wargenau M, et al. The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethyl starch 130/0. 4 (6%,500ml) in mild-to-servere renal impairment. Anesth Analg, 2002,95: 544-551.
